Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention, Division of Diabetes Translation, 4770 Buford Hwy, NE, MS S107-3, Atlanta, GA 30341-3724 (
Prev Chronic Dis. 2023 Aug 10;20:E70. doi: 10.5888/pcd20.220407.
In 2019 among US adults, 1 in 9 had diagnosed diabetes and 1 in 5 had diagnosed depression. Since these conditions frequently coexist, compounding their health and economic burden, we examined state-specific trends in depression prevalence among US adults with and without diagnosed diabetes.
We used data from the 2011 through 2019 Behavioral Risk Factor Surveillance System to evaluate self-reported diabetes and depression prevalence. Joinpoint regression estimated state-level trends in depression prevalence by diabetes status.
In 2019, the overall prevalence of depression in US adults with and without diabetes was 29.2% (95% CI, 27.8%-30.6%) and 17.9% (95% CI, 17.6%-18.1%), respectively. From 2011 to 2019, the depression prevalence was relatively stable for adults with diabetes (28.6% versus 29.2%) but increased for those without diabetes from 15.5% to 17.9% (average annual percent change [APC] over the 9-year period = 1.6%, P = .015). The prevalence of depression was consistently more than 10 percentage points higher among adults with diabetes than those without diabetes. The APC showed a significant increase in some states (Illinois: 5.9%, Kansas: 3.5%) and a significant decrease in others (Arizona: -5.1%, Florida: -4.0%, Colorado: -3.4%, Washington: -0.9%). In 2019, although it varied by state, the depression prevalence among adults with diabetes was highest in states with a higher diabetes burden such as Kentucky (47.9%), West Virginia (47.0%), and Maine (41.5%).
US adults with diabetes are more likely to report prevalent depression compared with adults without diabetes. These findings highlight the importance of screening and monitoring for depression as a potential complication among adults with diabetes.
2019 年，美国成年人中每 9 人就有 1 人被诊断患有糖尿病，每 5 人就有 1 人被诊断患有抑郁症。由于这些疾病经常同时存在，加重了他们的健康和经济负担，我们研究了美国患有和未患有糖尿病的成年人中抑郁症患病率的州特定趋势。
我们使用 2011 年至 2019 年行为风险因素监测系统的数据评估了自我报告的糖尿病和抑郁症患病率。联合点回归估计了按糖尿病状况划分的州一级抑郁症患病率趋势。
2019 年，美国患有和未患有糖尿病的成年人的总体抑郁症患病率分别为 29.2%（95%CI，27.8%-30.6%）和 17.9%（95%CI，17.6%-18.1%）。从 2011 年到 2019 年，糖尿病患者的抑郁症患病率相对稳定（28.6%对 29.2%），而未患糖尿病的成年人的患病率则从 15.5%上升到 17.9%（9 年期间的平均年百分比变化[APC]为 1.6%，P=.015）。患有糖尿病的成年人中抑郁症的患病率始终比没有糖尿病的成年人高 10 个百分点以上。在一些州，APCs 显示出显著增加（伊利诺伊州：5.9%，堪萨斯州：3.5%），而在另一些州，APCs 则显示出显著下降（亚利桑那州：-5.1%，佛罗里达州：-4.0%，科罗拉多州：-3.4%，华盛顿州：-0.9%）。2019 年，尽管各州情况有所不同，但在肯塔基州（47.9%）、西弗吉尼亚州（47.0%）和缅因州（41.5%）等糖尿病负担较高的州，患有糖尿病的成年人的抑郁症患病率最高。
与没有糖尿病的成年人相比，患有糖尿病的美国成年人更有可能报告普遍存在的抑郁症。这些发现强调了对成年人进行抑郁症筛查和监测的重要性，因为这可能是糖尿病的一种潜在并发症。
